Dataset Information

The absolute abundance of various metabolic enzymes measured by an iMPAQT method in young and nutlin3a-induced senescent (n-Sen) HCA2 cells.

ABSTRACT: For senescence induction, HCA2 humn skin fibroblasts were synchronized at G2 phase by treatment with 9 uM of RO3306 (Roche) for 24 hrs, treated with 9 uM of RO3306 and 5 uM of Nutlin3a (Sigma-Aldrich) for 8 hrs, and then with 5 uM of nutlin3a for 18 hrs. Cells were then treated with 100 nM of BI-2536 for 9 days to eliminate proliferating cells, and cultured in normal media for 9 days. The senescent and non-senescent (young) cells were collected, washed with PBS, snap-frozen, and analyzed with a iMPAQT method.

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Makoto Nakanishi

PROVIDER: PXD017100 | JPOST Repository | Fri Jan 15 00:00:00 GMT 2021

REPOSITORIES: jPOST

ACCESS DATA

Similar Datasets

Project description:Progesterone receptor (PR) and its co-activators are direct targets of activated cyclin dependent kinases (CDKs) in response to peptide growth factors, progesterone, and deregulation of cell cycle inhibitors. Herein, using the T47D breast cancer model, we probed mechanisms of cell cycle-dependent PR action. In the absence of exogenous progestin, PR is specifically phosphorylated during the G2/M phase. Accordingly, numerous PR target genes are cell cycle regulated, including HSPB8, a heat-shock protein whose high expression is associated with tamoxifen-resistance. Progestin-induced HSPB8 expression required cyclin D1 and was insensitive to anti-estrogens, but blocked by anti-progestins or inhibition of specificity factor 1 (SP1). HSPB8 expression increased with or without ligand when cells were G2/M synchronized or contained high levels of cyclin D1. Knock-down of PR abrogated ligand-independent HSPB8 expression in synchronized cells. Notably, PR and cyclin D1 co-purified in whole cell lysates of transiently transfected COS-1 cells and in PR-positive T47D breast cancer cells expressing endogenous cyclin D1. PR, cyclin D1, and SP1 were recruited to the HSPB8 promoter in progestin-treated T47D breast cancer cells. Mutation of PR Ser345 to Ala (S345A) or inhibition of CDK2 activity using roscovitine disrupted PR/cyclin D1 interactions with DNA and blocked HSPB8 mRNA expression. Interaction of phosphorylated PRs with SP1 and cyclin D1 provides a mechanism for targeting transcriptionally active PRs to selected gene promoters relevant to breast cancer progression. Understanding the functional linkage between PR and cell cycle regulatory proteins will provide keys to targeting novel PR/cyclin D1 cross-talk in both hormone-responsive and HSPB8-high refractory disease. The study contains 4 different sample groups measured in triplicate, for a total of 12 individual samples (12 arrays). In T47D human breast cancer cell lines stably expressing PR-B, cells were synchronized (or not synchronized) before G2/M phase using nocodazole. These cell lines (synchronized or not synchronized) were treated with either (1) vehicle control (ethanol) or (2) PR ligand R5020 10e-8 M for 6 hours before total RNA harvest. Thus, the experiment contains two cell lines, and two treatments (4 sample groups) treated and analyzed in triplicate (12 microarrays). Standard Illumina HT-12v4 chip controls were used during hybridization.

Dataset Information

The absolute abundance of various metabolic enzymes measured by an iMPAQT method in young and nutlin3a-induced senescent (n-Sen) HCA2 cells.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure